{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T23:50:44Z","timestamp":1794441044366,"version":"4.9.1"},"reference-count":67,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,8]],"date-time":"2024-04-08T00:00:00Z","timestamp":1712534400000},"content-version":"vor","delay-in-days":1254,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Medicine"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.7861\/clinmed.2020-0754","type":"journal-article","created":{"date-parts":[[2020,11,16]],"date-time":"2020-11-16T09:06:04Z","timestamp":1605517564000},"page":"580-587","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":87,"title":["Raynaud's phenomenon"],"prefix":"10.1016","volume":"20","author":[{"given":"Ashraful","family":"Haque","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.7861\/clinmed.2020-0754_bib1","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1093\/rheumatology\/kev002","article-title":"Prediction and impact of attacks of Raynaud's phenomenon, as judged by patient perception","volume":"54","author":"Hughes","year":"2015","journal-title":"Rheumatology (Oxford)"},{"key":"10.7861\/clinmed.2020-0754_bib2","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1093\/rheumatology\/keq310","article-title":"Frequency and impact of symptoms experienced by patients with systemic sclerosis: results from a Canadian National Survey","volume":"50","author":"Bassel","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"10.7861\/clinmed.2020-0754_bib3","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jpsychores.2018.11.001","article-title":"Comparison of mental and physical health between patients with primary and secondary Raynaud\u2019s phenomenon Category: Article","volume":"116","author":"F\u00e1bi\u00e1n","year":"2019","journal-title":"J Psychosom Res"},{"key":"10.7861\/clinmed.2020-0754_bib4","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1007\/s10067-019-04745-5","article-title":"Raynaud's phenomenon - an update on diagnosis, classification and management","volume":"38","author":"Pauling","year":"2019","journal-title":"Clin Rheumatol"},{"key":"10.7861\/clinmed.2020-0754_bib5","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1007\/s00296-011-1999-3","article-title":"Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors","volume":"31","author":"Gasparyan","year":"2011","journal-title":"Rheumatol Int"},{"key":"10.7861\/clinmed.2020-0754_bib6","series-title":"Raynaud's phenomenon","first-page":"21","article-title":"Epidemiology of Raynaud's phenomenon","author":"Maundrell","year":"2015"},{"key":"10.7861\/clinmed.2020-0754_bib7","doi-asserted-by":"crossref","first-page":"6389","DOI":"10.1136\/bmjopen-2014-006389","article-title":"Prevalence, risk factors and associations of primary Raynaud's phenomenon: Systematic review and meta-analysis of observational studies","volume":"5","author":"Garner","year":"2015","journal-title":"BMJ Open"},{"key":"10.7861\/clinmed.2020-0754_bib8","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1024\/0301-1526\/a000661","article-title":"ESVM guidelines - the diagnosis and management of Raynaud's phenomenon","volume":"46","author":"Belch","year":"2017","journal-title":"Vasa"},{"key":"10.7861\/clinmed.2020-0754_bib9","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1590\/1806-9282.65.10.1314","article-title":"Raynaud's phenomenon in the occupational context","volume":"65","author":"Cordeiro","year":"2019","journal-title":"Rev Assoc Med Bras"},{"key":"10.7861\/clinmed.2020-0754_bib10","first-page":"485","article-title":"Raynaud's phenomenon: a proposal for classification.","volume":"10","author":"LeRoy","year":"1992","journal-title":"Clin Exp Rheumatol"},{"key":"10.7861\/clinmed.2020-0754_bib11","first-page":"202","article-title":"Scleroderma (systemic sclerosis): classification, subsets and pathogenesis","volume":"15","author":"LeRoy","year":"1988","journal-title":"J Rheumatol"},{"key":"10.7861\/clinmed.2020-0754_bib12","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1136\/annrheumdis-2011-200742","article-title":"Update on the profile of the EUSTAR cohort: an analysis of the EULAR Scleroderma Trials and Research group database","volume":"71","author":"Meier","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.7861\/clinmed.2020-0754_bib13","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/S0398-0499(06)76512-X","article-title":"Aspects h\u00e9r\u00e9ditaires et g\u00e9n\u00e9tiques de la maladie de Raynaud","volume":"31","author":"Pistorius","year":"2006","journal-title":"J Mal Vasc"},{"key":"10.7861\/clinmed.2020-0754_bib14","doi-asserted-by":"crossref","first-page":"e0196279","DOI":"10.1371\/journal.pone.0196279","article-title":"Association of Raynaud's phenomenon with a polymorphism in the NOS1 gene","volume":"13","author":"Munir","year":"2018","journal-title":"PLoS One"},{"key":"10.7861\/clinmed.2020-0754_bib15","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1161\/01.CIR.77.5.988","article-title":"Apparent finger systolic pressures during cooling in patients with Raynaud's syndrome","volume":"77","author":"Carter","year":"1988","journal-title":"Circulation"},{"key":"10.7861\/clinmed.2020-0754_bib16","doi-asserted-by":"crossref","DOI":"10.5152\/eurjrheum.2020.19211","article-title":"Digital artery vasospasm in primary Raynaud's phenomenon","author":"Rogers","year":"2020","journal-title":"Eur J Rheumatol"},{"key":"10.7861\/clinmed.2020-0754_bib17","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nrrheum.2012.96","article-title":"The pathogenesis, diagnosis and treatment of Raynaud phenomenon","volume":"8","author":"Herrick","year":"2012","journal-title":"Nat Rev Rheumatol"},{"key":"10.7861\/clinmed.2020-0754_bib18","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/s41584-020-0386-4","article-title":"Raynaud's phenomenon and digital ulcers in systemic sclerosis","volume":"4","author":"Hughes","year":"2020","journal-title":"Nat Rev Rheumatol"},{"key":"10.7861\/clinmed.2020-0754_bib19","doi-asserted-by":"crossref","first-page":"101474","DOI":"10.1016\/j.berh.2019.101474","article-title":"Raynaud's phenomenon","volume":"34","author":"Herrick","year":"2020","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.7861\/clinmed.2020-0754_bib20","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.17219\/acem\/75618","article-title":"Analysis of peripheral nerve and autonomic nervous system function and the stage of microangiopathy in patients with secondary Raynaud\u2019s phenomenon in the course of connective tissue diseases","volume":"27","author":"Gosk-Bierska","year":"2018","journal-title":"Adv Clin Exp Med"},{"key":"10.7861\/clinmed.2020-0754_bib21","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1161\/01.RES.0000128407.45014.58","article-title":"Rho kinase mediates cold-induced constriction of cutaneous arteries: Role of \u03b12C-adrenoceptor translocation","volume":"94","author":"Bailey","year":"2004","journal-title":"Circ Res"},{"key":"10.7861\/clinmed.2020-0754_bib22","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1161\/01.CIR.92.6.1448","article-title":"Blockade of vasospastic attacks by alpha 2-adrenergic but not alpha 1-adrenergic antagonists in idiopathic Raynaud's disease","volume":"92","author":"Freedman","year":"1995","journal-title":"Circulation"},{"key":"10.7861\/clinmed.2020-0754_bib23","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1016\/0140-6736(90)93307-B","article-title":"Deficiency of calcitonin gene-related peptide in Raynaud's phenomenon","volume":"336","author":"Bunker","year":"1990","journal-title":"Lancet"},{"key":"10.7861\/clinmed.2020-0754_bib24","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1093\/rheumatology\/36.10.1045","article-title":"The coagulation\/fibrinolytic balance in systemic sclerosis: evidence for a haematological stress syndrome","volume":"37","author":"Ames","year":"1997","journal-title":"Br J Rheumatol"},{"key":"10.7861\/clinmed.2020-0754_bib25","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/MBC.0b013e328010bd05","article-title":"Increased circulating platelet-leucocyte complexes in patients with primary Raynaud's phenomenon and Raynaud's phenomenon secondary to systemic sclerosis: a comparative study","volume":"18","author":"Pamuk","year":"2007","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.7861\/clinmed.2020-0754_bib26","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1093\/rheumatology\/keh552","article-title":"Pathogenesis of Raynaud's phenomenon","volume":"44","author":"Herrick","year":"2005","journal-title":"Rheumatology (Oxford)"},{"key":"10.7861\/clinmed.2020-0754_bib27","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jaut.2014.01.020","article-title":"International consensus criteria for the diagnosis of Raynaud\u2019s phenomenon","volume":"48\u201349","author":"Maverakis","year":"2014","journal-title":"J Autoimmun"},{"key":"10.7861\/clinmed.2020-0754_bib28","doi-asserted-by":"crossref","first-page":"658","DOI":"10.12968\/hmed.2019.80.11.658","article-title":"Raynaud's phenomenon","volume":"80","author":"Devgire","year":"2019","journal-title":"Br J Hosp Med (Lond)"},{"key":"10.7861\/clinmed.2020-0754_bib29","doi-asserted-by":"crossref","first-page":"783","DOI":"10.3899\/jrheum.091117","article-title":"Thumb involvement in Raynaud's phenomenon as an indicator of underlying connective tissue disease","volume":"37","author":"Chikura","year":"2010","journal-title":"J Rheumatol"},{"key":"10.7861\/clinmed.2020-0754_bib30","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.semarthrit.2016.05.001","article-title":"Differential diagnosis of critical digital ischemia in systemic sclerosis: Report of five cases and review of the literature","volume":"46","author":"Sharp","year":"2016","journal-title":"Semin Arthritis Rheum"},{"key":"10.7861\/clinmed.2020-0754_bib31","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1007\/s10067-020-05128-x","article-title":"Large vessel disease as a potentially treatable cause of devastating critical digital ischaemia in systemic sclerosis","volume":"39","author":"Haque","year":"2020","journal-title":"Clin Rheumatol"},{"key":"10.7861\/clinmed.2020-0754_bib32","doi-asserted-by":"crossref","first-page":"3902","DOI":"10.1002\/art.24038","article-title":"Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud's phenomenon to systemic sclerosis: A twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis","volume":"58","author":"Koenig","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.7861\/clinmed.2020-0754_bib33","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1093\/rheumatology\/kev201","article-title":"Consensus best practice pathway of the UK Scleroderma Study Group: digital vasculopathy in systemic sclerosis","volume":"54","author":"Hughes","year":"2015","journal-title":"Rheumatology (Oxford)"},{"key":"10.7861\/clinmed.2020-0754_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2020.06.018","article-title":"Performance of laser-derived imaging for assessing digital perfusion in clinical trials of systemic sclerosis-related digital vasculopathy: A systematic literature review","author":"Pauling","year":"2020","journal-title":"Semin Arthritis Rheum"},{"key":"10.7861\/clinmed.2020-0754_bib35","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1007\/s10067-006-0489-6","article-title":"Office capillaroscopy in systemic sclerosis","volume":"26","author":"Baron","year":"2007","journal-title":"Clin Rheumatol"},{"key":"10.7861\/clinmed.2020-0754_bib36","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1093\/rheumatology\/keu533","article-title":"A study comparing videocapillaroscopy and dermoscopy in the assessment of nailfold capillaries in patients with systemic sclerosis-spectrum disorders","volume":"54","author":"Hughes","year":"2015","journal-title":"Rheumatology (Oxford)"},{"key":"10.7861\/clinmed.2020-0754_bib37","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1002\/art.1780160506","article-title":"Patterns of finger capillary abnormalities in connective tissue disease by \u201cwide-field\u201d microscopy","volume":"16","author":"Maricq","year":"1973","journal-title":"Arthritis Rheum"},{"key":"10.7861\/clinmed.2020-0754_bib38","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.3899\/jrheum.130528","article-title":"Nailfold capillaroscopy for prediction of novel future severe organ involvement in systemic sclerosis","volume":"40","author":"Smith","year":"2013","journal-title":"J Rheumatol"},{"key":"10.7861\/clinmed.2020-0754_bib39","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1002\/art.39718","article-title":"Nailfold videocapillaroscopic features and other clinical risk factors for digital ulcers in systemic sclerosis: a multicenter, prospective cohort study","volume":"68","author":"Cutolo","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"10.7861\/clinmed.2020-0754_bib40","doi-asserted-by":"crossref","first-page":"102394","DOI":"10.1016\/j.autrev.2019.102394","article-title":"Fast track algorithm: How to differentiate a \u201cscleroderma pattern\u201d from a \u201cnon-scleroderma pattern\u201d","volume":"18","author":"Smith","year":"2019","journal-title":"Autoimmun Rev"},{"key":"10.7861\/clinmed.2020-0754_bib41","doi-asserted-by":"crossref","first-page":"102458","DOI":"10.1016\/j.autrev.2020.102458","article-title":"Standardisation of nailfold capillaroscopy for the assessment of patients with Raynaud's phenomenon and systemic sclerosis","volume":"19","author":"Smith","year":"2020","journal-title":"Autoimmun Rev"},{"key":"10.7861\/clinmed.2020-0754_bib42","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1093\/rheumatology\/kel330","article-title":"The \u201cdistal-dorsal difference\u201d: a thermographic parameter by which to differentiate between primary and secondary Raynaud\u2019s phenomenon","volume":"46","author":"Anderson","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"10.7861\/clinmed.2020-0754_bib43","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1002\/art.40457","article-title":"A multicenter study of the validity and reliability of responses to hand cold challenge as measured by laser speckle contrast imaging and thermography: outcome measures for systemic sclerosis-related Raynaud's phenomenon","volume":"70","author":"Wilkinson","year":"2018","journal-title":"Arthritis Rheumatol"},{"key":"10.7861\/clinmed.2020-0754_bib44","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/psb.1590","article-title":"Assessment and management of Raynaud's phenomenon","volume":"28","author":"Hughes","year":"2017","journal-title":"Prescriber"},{"key":"10.7861\/clinmed.2020-0754_bib45","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1136\/annrheumdis-2018-214161","article-title":"Patient organisation-led initiatives can play an important role in raising awareness about Raynaud's phenomenon and encourage earlier healthcare utilisation for high-risk groups","volume":"78","author":"Hughes","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"10.7861\/clinmed.2020-0754_bib46","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1007\/s10067-020-05023-5","article-title":"A systematic review of internet-based information for individuals with Raynaud's phenomenon and patients with systemic sclerosis","volume":"39","author":"Devgire","year":"2020","journal-title":"Clin Rheumatol"},{"key":"10.7861\/clinmed.2020-0754_bib47","first-page":"798","article-title":"Recent advances in the workup and management of Raynaud phenomenon","volume":"129","author":"Lis-S\u00b4wie\u02dbty","year":"2019","journal-title":"Polish Arch Intern Med"},{"key":"10.7861\/clinmed.2020-0754_bib48","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1093\/rheumatology\/kew224","article-title":"BSR and BHPR guideline for the treatment of systemic sclerosis","volume":"55","author":"Denton","year":"2016","journal-title":"Rheumatology (Oxford)"},{"key":"10.7861\/clinmed.2020-0754_bib49","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1002\/art.40560","article-title":"Treatment algorithms for systemic sclerosis according to experts","volume":"70","author":"Fern\u00e1ndez-Codina","year":"2018","journal-title":"Arthritis Rheumatol"},{"key":"10.7861\/clinmed.2020-0754_bib50","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1136\/annrheumdis-2014-207001","article-title":"Efficacy of sildenafil on ischaemic digital ulcer healing in systemic sclerosis: the placebo-controlled SEDUCE study","volume":"75","author":"Hachulla","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.7861\/clinmed.2020-0754_bib51","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s10238-019-00553-y","article-title":"Iloprost use and medical management of systemic sclerosis-related vasculopathy in Italian tertiary referral centers: results from the PROSIT study","volume":"19","author":"Negrini","year":"2019","journal-title":"Clin Exp Med"},{"key":"10.7861\/clinmed.2020-0754_bib52","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1177\/1060028016660324","article-title":"Evidence for the use of epoprostenol to treat Raynaud's phenomenon with or without digital ulcers","volume":"50","author":"Cruz","year":"2016","journal-title":"Ann Pharmacother"},{"key":"10.7861\/clinmed.2020-0754_bib53","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s40674-018-0102-6","article-title":"Pharmacotherapy options in the management of Raynaud's phenomenon","volume":"4","author":"Hinze","year":"2018","journal-title":"Curr Treat Options Rheumatol"},{"key":"10.7861\/clinmed.2020-0754_bib54","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1136\/ard.2010.130658","article-title":"Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial","volume":"70","author":"Matucci-Cerinic","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.7861\/clinmed.2020-0754_bib55","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1001\/jama.2016.5258","article-title":"Effect of Macitentan on the development of new ischemic digital ulcers in patients with systemic sclerosis: DUAL-1 and DUAL-2 randomized clinical trials","volume":"315","author":"Khanna","year":"2016","journal-title":"JAMA"},{"key":"10.7861\/clinmed.2020-0754_bib56","doi-asserted-by":"crossref","first-page":"e102","DOI":"10.1016\/j.jaad.2011.04.029","article-title":"Combination therapy with an endothelin-1 receptor antagonist (bosentan) and a phosphodiesterase V inhibitor (sildenafil) for the management of severe digital ulcerations in systemic sclerosis","volume":"65","author":"Moinzadeh","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.7861\/clinmed.2020-0754_bib57","doi-asserted-by":"crossref","first-page":"j5492","DOI":"10.1136\/bmj.j5492","article-title":"Pulmonary arterial hypertension: pathogenesis and clinical management","volume":"360","author":"Thenappan","year":"2018","journal-title":"BMJ"},{"key":"10.7861\/clinmed.2020-0754_bib58","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/SAP.0000000000000614","article-title":"Digital sympathectomy in patients with scleroderma: an overview of the practice and referral patterns and perceptions of rheumatologists","volume":"75","author":"Chiou","year":"2015","journal-title":"Ann Plast Surg"},{"key":"10.7861\/clinmed.2020-0754_bib59","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1002\/art.40123","article-title":"The therapeutic efficacy of botulinum toxin in treating scleroderma-associated Raynaud's phenomenon: a randomized, double-blind, placebo-controlled clinical trial","volume":"69","author":"Bello","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"10.7861\/clinmed.2020-0754_bib60","doi-asserted-by":"crossref","first-page":"3669","DOI":"10.1007\/s10067-019-04762-4","article-title":"Optimisation of botulinum toxin type a treatment for the management of Raynaud's phenomenon using a dorsal approach: a prospective case series","volume":"38","author":"Dhaliwal","year":"2019","journal-title":"Clin Rheumatol"},{"key":"10.7861\/clinmed.2020-0754_bib61","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1177\/2397198318774307","article-title":"Patient-reported outcome instruments for assessing Raynaud's phenomenon in systemic sclerosis: A SCTC vascular working group report","volume":"3","author":"Pauling","year":"2018","journal-title":"J Scleroderma Relat Disord"},{"key":"10.7861\/clinmed.2020-0754_bib62","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1002\/acr.23475","article-title":"Multinational qualitative research study exploring the patient experience of Raynaud's phenomenon in systemic sclerosis","volume":"70","author":"Pauling","year":"2018","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.7861\/clinmed.2020-0754_bib63","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/acr.24127","article-title":"Multicenter qualitative study exploring the patient experience of digital ulcers in systemic sclerosis","volume":"72","author":"Hughes","year":"2020","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.7861\/clinmed.2020-0754_bib64","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1093\/rheumatology\/kez522","article-title":"Drug initiation and escalation strategies of vasodilator therapies for Raynaud's phenomenon: can we treat to target","volume":"59","author":"Hughes","year":"2020","journal-title":"Rheumatology (Oxford)"},{"key":"10.7861\/clinmed.2020-0754_bib65","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.mvr.2016.12.008","article-title":"Reduced perfusion in systemic sclerosis digital ulcers (both fingertip and extensor) can be increased by topical application of glyceryl trinitrate","volume":"111","author":"Hughes","year":"2017","journal-title":"Microvasc Res"},{"key":"10.7861\/clinmed.2020-0754_bib66","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.jaad.2018.01.043","article-title":"A systematic review and meta-analysis of the effects of topical nitrates in the treatment of primary and secondary Raynaud's phenomenon","volume":"78","author":"Curtiss","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"10.7861\/clinmed.2020-0754_bib67","doi-asserted-by":"crossref","first-page":"594","DOI":"10.3390\/pharmaceutics11110594","article-title":"Development of a UV-stabilized topical formulation of nifedipine for the treatment of Raynaud phenomenon and chilblains","volume":"11","author":"Wasan","year":"2019","journal-title":"Pharmaceutics"}],"container-title":["Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1470211824034274?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1470211824034274?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.7861\/clinmed.2020-0754","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T06:40:12Z","timestamp":1761460812000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1470211824034274"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":67,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S1470211824034274"],"URL":"https:\/\/doi.org\/10.7861\/clinmed.2020-0754","relation":{},"ISSN":["1470-2118"],"issn-type":[{"value":"1470-2118","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Raynaud's phenomenon","name":"articletitle","label":"Article Title"},{"value":"Clinical Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.7861\/clinmed.2020-0754","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 Royal College of Physicians 2020. All rights reserved.","name":"copyright","label":"Copyright"}]}}